BPC-157 use rose 33-fold in six years, according to clinical notes. That is not evidence it works

· News · News Desk

An nference analysis of 15 million+ medical records found 1,039 documented BPC-157 users. The study measures popularity, not efficacy — and its own authors say so.

This brief is part of the Novusyn Research news desk. We track peptide clinical readouts, regulatory actions, and pharma developments in neutral, evidence-led language for scientifically literate readers.

For related context, see the full news desk, clinical trials tracker, regulation tracker, compound directory, and guides library.